Policy Watch

  • Your Selections:

Refine Results

date

Type

Topics

Tags

Drew Altman: Understanding the US Failure on Coronavirus

For The BMJ, Drew Altman discusses two fundamental policy decisions made by the Trump administration that set the U.S. on the controversial and highly criticized course it has taken on COVID-19.

Where To Start To Build Vaccine Confidence

In this Axios column Drew Altman writes about the recent attention to Republican vaccine resisters. “Republicans and rural Americans are among the most resistant vaccine holdouts and some strategies are emerging to reach them.” But “far from all Republicans are resisters” and “the bigger and quicker payoff will come from prioritizing the more moveable group of ‘wait and see’ Americans.”

Black Americans Are More Skeptical of a Coronavirus Vaccine

Drew Altman discusses how systemic racism has led to striking levels of reluctance to get a COVID-19 vaccine among Black Americans, including those at highest risk, and the challenge it presents for ending the pandemic.

How Full FDA Approval Could Spur Vaccination

In this Axios column, Drew Altman says full FDA approval of COVID-19 vaccines can provide a big boost to vaccination efforts if treated as an opportunity for updated messaging from government officials at all levels and public health experts and new actions from employers.

Drew Altman: The Pandemic is Boosting the Public’s View of Doctors

In this Axios column, Drew Altman looks at how the heroic performance of the nation’s doctors on the frontlines of coronavirus care and effective communication by many physician scientists on television, is shifting the public’s views, with twice as many Americans now saying doctors put people ahead of profits than they did in earlier KFF polling.

Drugs Aren’t the Reason the U.S. Spends So Much on Health Care

Drew Altman’s column in Axios: the U.S. now spends twice per capita what other wealthy countries do on health care. But while drug costs get all the time in public debate, it’s hospital and outpatient spending that mostly explains the difference. And that will be impossible to take on without real pain and political risk, he says.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.